Epilepsy: treatment in developing countries

Manjari Tripathi MD (Dr. Tripathi of All India Institute of Medical Sciences in New Delhi, India, has no relevant financial relationships to disclose.)
John M Stern MD, editor. (

Dr. Stern, Director of the Epilepsy Clinical Program at the University of California in Los Angeles, received honorariums from Greenwish, Sunovion, and UCB as an advisor and from Greenwich, Eisai, LivaNova, and UCB as a lecturer.

Originally released October 14, 2009; last updated: March 30, 2014; expires March 30, 2017
Notice: This article has expired and is therefore not available for CME credit.


About 85% of persons with epilepsy inhabit the developing world. Recent studies in developed and developing countries have shown that up to 70% of newly diagnosed children and adults with epilepsy can be successfully treated with antiepileptic drugs. In these regions, more than 60% of people with epilepsy may not receive the treatment they need. This wide treatment gap in these regions needs to be narrowed to decrease morbidity and mortality due to epilepsy.

The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.

If you are a subscriber, please log in.

If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.

If you have never registered before, click Learn More about MedLink Neurology  or view available Service Plans.